Close Menu

Beckman Coulter

Affymetrix and Beckman Coulter will develop a platform combining their technologies for automated target preparation.

Beckman Coulter will offer the automated platform with its won CyAn flow cytometers.

The new Beckman unit, which offers genomic services such as sequencing, sample prep, genotyping, gene expression, and biological efficiency and safety testing, is headquartered in Beverly, Mass., where Agencourt is located.

Beckman Coulter's new genomics business merges the offerings of Agencourt Bioscience with Cogenics.

Beckman Coulter completed the $780 million deal over this past weekend.

Gains for Beckman Coulter's recurring revenues were offset by a decrease in cash instrument sales.

The firm will make a quarterly dividend payment for the 81st consecutive quarter.

The suit, which centered around SNP genotyping technologies and patents, was dismissed a couple of weeks after a Markman hearing in the case.

Beckman Coulter's first-quarter revenues fell 5.3 percent, but were flat in constant currency terms, as the firm's cash instrument sales declined. The firm's life science and cellular analysis instruments were hit particularly hard by the constrained capital expenditure market.

PGx & molecular Dx


A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.